| row-start col-md-7 #top-section top-section #about-section no-pad-bottom-section |
Meet the Delegates from the UK's Northern Powerhouse region
Foreword:
We are delighted to bring a delegation of companies from the North of England, also known as the Northern Powerhouse to Medica 2023. The mission offers unique opportunities to build ties with key decision makers and innovators around the world for delegates and buyers alike.
The UK boasts a strong heritage in the life sciences and healthcare sectors. From the pioneering discovery of the structure of DNA to the development of Computer Tomography (CT) and Magnetic Resonance Imaging (MRI) the UK has always been a world leader in medical innovation. This innovation has continued into the 21st Century with the UK leading the way in areas such as regenerative medicine, antibody therapies and the application of robotic surgery technology. These advances demonstrate the important contribution that UK science and medicine is making to radically improve patient care.
The healthcare and the life sciences sectors are one of most dynamic and productive sectors in the Northern economy and the UK and has one of the largest clusters of orthopedic, medical device and surgical companies in the UK and is home to many innovative and ground- breaking companies. Over 1,000 life sciences companies in the Northern Powerhouse with the aim to contribute to economic growth and prosperity while supporting and creating highly skilled jobs.
The North has many centres of excellence, including the home of wonder material graphene in Manchester, a centre of excellence in precision medicine in Leeds, the School of Tropical Medicine in Liverpool, the Institute for Ageing in Newcastle and one of the UK’s largest medical devices clusters in Sheffield. The Northern Powerhouse’s life sciences sectors unite a wealth of world-class expertise and business talent.
The North is a place where businesses and industry prosper. To find out what the North has to offer and to meet the businesses on this trade mission, please read on.
Liz Bennington
Deputy Director North (England)
Department for Business and Trade
| row-end col-md-5 col-sm-12 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| row-start col-md-12 no-pad-top-section |
Meet the Delegates from the UK's Northern Powerhouse region
|
David Heathcote - Head of Business Development
Visit: www.innerva.com
Email: david.heathcote@innerva.com
Tel: +44 (0)7909 526072
Company Profile:
Innerva is a British designer and manufacturer of power assisted exercise rehabilitation therapy technology, providing a preventative physical activity solution for older adults and those living with long-term medical and health conditions. With over 30 years of engineering excellence, Innerva provides exercise therapy equipment to health, therapy and rehabilitation, leisure, retirement and care facilities around the world.
Designed in partnership with leading British universities and the Advanced Wellbeing Research Centre, Innerva facilitates active assisted range of motion for end users. Unlike conventional exercise equipment, Innerva technology does not rely exclusively on muscle power, but engages an electronic power system enabling users to work passively or actively, depending on their ability. Innerva provides safe exercise to all the major muscle groups and helps to re-train movement patterns, whilst stimulating metabolic and circulatory systems.
The British Government recently commissioned Innerva to help reduce barriers to preventative exercise therapy for older adults.
Objectives of attending Medica 2023:
• Meet potential distributors in health, rehabilitation/therapy, leisure, retirement, care
• Meet strategic partners
• Meet health stakeholders/politicians
Sectors: Healthcare Services, Publications and NHS
Follow us:
LinkedIn | X/Twitter | Facebook | Instagram
Back to Top
Dr Sam Whitehouse - CEO
Visit: www.lightox.co.uk
Email: contact@lightox.co.uk
Company Profile:
LightOx has developed a light activated treatment for the control of infection in wounds.
LightOx’s active compounds are able to penetrate into bacterial cells and on the addition of light kill bacterial and microbial species. This infection control treatment can be placed into wound dressings and hydrogels to manage and maintain a sterile wound environment and aid the healing process.
LightOx has developed light activated drugs for the treatment of oral cancer. LXD191 can be applied topically to cancerous lesions in the oral cavity and activity using a specific light source to treat the oral dysplasia.
Objectives of attending Medica 2023:
• Find partners in wound healing, anti-microbial and bacterial infection
• Find partners in Oral cancer treatment
Sectors: Medical Technology, Oral Cancer, Wound Care, Anti-microbial
Follow us:
Back to Top
Arun Kumar - International Sales Director
Visit: www.marsden-weighing.co.uk
Email: arun@marsdengroup.co.uk
Tel: +44 (0)7917 993573
Company Profile:
Experts within the weighing industry, we understand the importance of weighing and patient monitoring. Medical professionals rely on Marsden for reliability, accuracy and value for money.
Marsden is dedicated to developing highly accurate MDR-compliant weighing devices. Providing innovative new solutions for a wide range of sectors and maintaining a high standard of customer service. Our product range includes Baby, Chair, Bed, Floor, Stand, Hoist and Wheelchair Scales.
Our most innovative product is the Patient Transfer Scale (PTS), an innovative solution for weighing immobile patients. The PTS was developed by an NHS nurse, who wanted to ensure patient safety of the most critical patients and was prioritised with this simple and innovative solution.
Objectives of attending Medica 2023:
• Looking to find an agent or distributor
• Network with other UK partners
Sectors: Medical Technology, Hospital Equipment
Follow us:
Back to Top
Guy Latham - UK & International Sales Manager
Visit: www.medasil.com
Email: glatham@medasil.com
Tel: +44 (0)7507 976553
Company Profile:
Medasil Surgical Limited is a family-owned company based in the city of Leeds, West Yorkshire. Established in 1974 by the founder Mr Reuben Vincent, we have been providing an unrivalled range of quality products to the healthcare sector for almost 50 years.
Medasil is primarily a silicone manufacturer, specialising in injection moulding, extrusion and press moulding of single-use medical devices and other products. We manufacture, assemble, package and supply products under our brand as well as for other companies. Our product range includes ENT, General Surgical Devices, Wound Drains, Tubing and our LASERGUARD range of laser protection devices.
Customers include the NHS, private hospitals and other healthcare facilities in the UK and Worldwide. Our focus is on improving patient outcomes and helping healthcare professionals deliver excellence in service; we place the patient at the core of our business.
Objectives of attending Medica 2023:
• Look for products to distribute in the UK, new suppliers, and distribution partners for our products
• Look for new materials and machinery
• Look for innovation and new ideas
Sectors: Medical Technology, Wound Care
Follow us:
LinkedIn | X/Twitter
Back to Top
Adam Milward - Cofounder & CEO
Visit: www.metadataworks.co.uk
Email: hello@metadataworks.co.uk
Tel: +44 (0)7496 916610
Company Profile:
Data usage in distributed organisations is often broken. Data engineers are overwhelmed with requests for information - spending much of their time answering ad-hoc data queries. Data users struggle to find, understand and access information. The result is slow, irrelevant, or even erroneous research.
MetadataWorks provides the foundations that make your data usable and helps you achieve your data goals. Our end-to-end metadata management solution has three layers: A business metadata catalogue, professional services, and an intuitive user interface that all users can understand. Designed especially for government, research and healthcare organisations, MetadataWorks’ solution allows data teams to reduce data search efforts, accelerate data readiness and make data usable.
Sectors: Healthcare Services, Publications and NHS
Follow us:
LinkedIn | X/Twitter
Back to Top
Dr Dawn Price - Managing Director
Visit: www.choiceandmedication.org
Email: dawn.price@misturainfromatics.org
Tel: +44 (0)7732 623547
Company Profile:
Mistura Informatics Ltd are former NHS clinicians that now provide digital medicines information systems to improve safety with medicines, reduce waste, quickens consultation time and improve health outcomes.
What’s my Drug? (WmD?) is a new innovation that provides simplified summary information as text monographs, easy read pictograms and short phrases with translations to any language. Access is via QR code scanning, touch screen platforms in patient facing clinical areas or via link that can be sent during remote consultations.
WmD? is a 2023 HETT (Health Excellence Through Technology) innovation nominated by the Academic Health Science Network in the UK. In addition to improved safety, and reduced waste, real world evidence show WmD? also improves clinical workflow and patient experience of health service provision. WmD? is now available for export to international health service providers. For more information: www.mappsorg.com
Objectives of attending Medica 2023:
• To find B2B partners to present whatsmydrug? within different countries
• To understand healthcare professionals regulation within other countries and make contact with regulators
• To meet with key stakeholders for healthcare service providers within different countries that can purchase whatsmydrug?
Hoping to connect with: Key personnel from international health service providers
Sectors:Medical Technology, Digital Health
Follow us:
LinkedIn | Facebook
Back to Top
Jo Idowu - Managing Director
Visit: www.providion.co.uk
Email: jidowu@providion.co.uk
Tel: +44 (0)7843 280913
Company Profile:
Providion is a leading independent provider of innovative training and service solutions for LC-MS systems. We specialise in the service and support of Waters & Sciex Mass Spectrometry equipment. Our team of product experts delivers everything from technical training courses, preventative maintenance visits to full service contracts.
We offer technical support, quality spare parts, refurbished instruments, factory repairs and rapid response to instrument breakdowns. We are proud to support many large pharmaceutical companies, contract research organisations, universities and drug discovery businesses as part of our expanding customer base. Offering annual service contracts, preventive maintenance and repairs tailored to your needs we keep instrument up-time as a priority for all our customers worldwide.
Providion is committed to assisting customers with their unique needs by providing them with comprehensive, quality assured solutions and professional, personal service.
Objectives of attending Medica 2023:
• Meet prospective customers
• Carry out market research
• Meet potential employees
Hoping to connect with: Pharmaceutical businesses, contract research labs, hospitals, universities using lab equipment, clinical labs
Sectors: Biotechnology and Pharmaceuticals Healthcare Services, Publications and NHS, Laboratory and Testing, Research and Development
Follow us:
LinkedIn | X/Twitter
Back to Top
Paul Marshall - CEO
Visit: www.rapidfluidics.com
Email: paul@rapidfluidics.com
Tel: +44 (0)7905 104566
Company Profile:
Rapid Fluidics is a world-leading microfluidics provider. We offer design, prototyping and manufacturing services using a novel approach to rapidly and accurately produce microfluidic systems. This offers a much faster iteration cycle through designs, at lower cost, reducing the time and cost of product development.
While the majority of our customers are involved in medical diagnostics, we also work in drug discovery and delivery projects, defence, space, cosmetics, reproductive health and water and environmental monitoring. Using microfluidics allows our customers to automate their processes, enabling their overall systems to be substantially reduced in size to reach the point of need.
Objectives of attending Medica 2023:
• Introduce Rapid Fluidics' services to new customers
• Reconnect with existing customers to discuss future work
• Develop strategic partnerships with similar companies
Hoping to connect with: We work with customers of all sizes, from academic research groups, spinouts and startups to global corporations. We provide outsourced engineering design and prototyping so our clients can de-risk their projects, reducing time and costs. We can get involved at any point, from the early research stage to providing design for mass-manufacture advice
Sectors: Biotechnology and Pharmaceuticals, Research and Development
Follow us:
LinkedIn | Instagram
Back to Top
Ian Baker - Business Development Director
Visit: www.schultzmedical.co.uk
Email: ian.baker@schultzmedical.co.uk
Tel: +44 (0)7783 339773
Company Profile:
Schultz Medical is based in the North West of England, and we are a manufacturer and supplier of CE certified single use and reusable medical instruments and are an ISO 9001 & 13485 accredited company. Our goal is to be the best value supplier of single use medical instruments in the UK.
Our core categories are Hysteroscopy (Diagnostic and Surgical instruments), Gynaecology, Electro-surgical (both instruments and generators), Ophthalmic Instruments and Dental Instruments.
We proudly supply the NHS and Private Hospitals across the UK as well as a number of export markets. Our services include the supply of Schultz Medical branded devices or the support of OEM branding under our registrations.
Objectives of attending Medica 2023:
• Meet distributors in target markets
• Source some new suppliers on surgical
• Source possible agents
Hoping to connect with: Distributors that have direct relationships with the healthcare providers eg hospitals and clinics in market
Sectors: Medical Technology Dental and Maxillofacial, Hospital Equipment, Imaging and Diagnostics, Surgical Devices and Operating Technology
Follow us:
Back to Top
Harry Singh - CEO
Visit: www.trupcr.com
Email: hsingh@trupcr.com
Tel: +44 (0) 7816 167 394
Company Profile:
TRUPCR Europe (Manchester, UK) is a molecular diagnostics company that develops, manufactures, and supplies the world’s largest range (100+) of high-quality CE-IVD qPCR kits in the areas of Oncology, Haemato-oncology, Infectious disease, AMR, and Genetics.
In addition the company has recently launched an NGS portfolio with its first product in the range being a Solid Tumour Panel Kit.
Come and join our welcoming team at the DBT Stand, who will be happy to discuss TRUPCR’s range of robust, sensitive, and easy-to-use kits.
Objectives of attending Medica 2023:
• Meeting with distributors
• Increase brand awareness especially in Europe
• Discover what other similar companies are developing and launching
Sectors: Oncology, Haemato-oncology, Infectious disease, AMR, Genetics
Follow us:
LinkedIn | X/Twitter
Back to Top
Ruby Williams - Key Account Manager Europe
Visit: www.contrelle.com
Email: ruby.williams@vernacare.com
Tel: +44 (0)796 6587178
Company Profile:
We are an award winning global supplier of everyday healthcare essentials. We work to create quality products which are proven to help improve the lives of patients, residents and healthcare professionals by reducing the risk of healthcare-associated infections. As pioneers for safe and hygienic care, we continue to innovate and collaborate in the areas of single-use toileting systems, personal hygiene, environmental cleaning, skin integrity and surgical solutions, pushing the standard of care forward, helping people lead longer more dignified lives.
We develop and manufacture a large number of leading brands within the healthcare sector - used every day in healthcare settings around the world- all with a focus on reducing risk and enhancing dignity. For more than half a century, ensuring the safety of people who use our products, has been at the heart of what we do. Our dedicated Regulatory Affairs department specialise in ensuring that the supply of our products are safe for their intended use before they reach the market, complying with all laws and regulations where they are sold.
Objectives of attending Medica 2023:
• Network with Key opinion leaders
• Meet experts who can give advice on entry to markets and tips on appointing great Distributions partners
• Meet distribution partners to potentially discuss partnerships to further expand Vernacare’s growing international presence
Sectors: Medical Technology, Research and Development
Follow us:
Back to Top
Andrew Tasker - CEO
Visit: www.contrelle.com
Email: andrew.tasker@vivecabiomed.co.uk
Tel: +44 (0)771 4749766
Company Profile:
Viveca Biomed is a special female healthcare business, marketing Contrelle Activgard, a unique and innovative bladder support for female bladder leakage (class IIA CE mark). Contrelle can replace the need for incontinence pads for many women - stopping leakage immediately.
Contrelle addresses the biggest patient need in healthcare where there are a lack of treatment options - a condition which effects 1 in 3 women globally.
100% of manufacturing takes place at our advanced ISO13485 facility North East England where the business supplies the UK market directly, (supplying direct to the consumer, via Boots, via pharmacy,to the NHS) and is rapidly expanding its international business - already has a network of highly qualified distribution partners across European and Global markets, with major opportunity to expand to all global markets.
The business also has an active new product development to reinforce its leadership position in pelvic health and a comprehensive female health portfolio.
Objectives of attending Medica 2023:
• Meet experienced partners/ distributors in North America, South America and Middle East /Africa
Sectors: Medical Technology, Research and Development
Follow us:
LinkedIn | Facebook | Instagram
Back to Top
